Article Text

PDF
Results of a pilot screening programme for genital and extragenital gonococcal and chlamydial infections in a military population following the repeal of ‘Don't Ask, Don't Tell’
  1. Tida Lee1,
  2. Anuradha Ganesan1,2
  1. 1 Walter Reed National Military Medical Center, Bethesda, Maryland, USA
  2. 2 Infectious Disease Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
  1. Correspondence to Anuradha Ganesan, Walter Reed National Military Medical Center, Division of Infectious Diseases, 8901, Wisconsin Avenue, Bethesda, MD 20889, USA; anuradha.ganesan.ctr@mail.mil

Statistics from Altmetric.com

In the care of the active duty HIV-positive population, there has been a shift in evaluation and data with the Department of Defense repeal of the ‘don't ask, don't tell’ (DADT) policy in September 2011.1 DADT allowed homosexual persons to serve in the military, but made it unlawful for service members to be asked about their orientation or for them to reveal their orientation. This policy made it difficult to screen for asymptomatic rectal and pharyngeal STIs. Since the repeal, service members are now able to reveal their sexual orientation without concern for repercussion.

Since September 2011, additional nucleic acid amplification test based screening of rectal and pharyngeal Neisseria gonorrhoeae (NG)/Chlamydia trachomatis (CT) was offered to patients at their biannual visits to the Walter Reed National Military Medical Center Infectious Disease Clinic. We performed retrospective analysis to …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.